Clinician’s Perspectives on the use of Vildagliptin and its Fixed-Dose Combination with Metformin in the Management of Type 2 Diabetes Mellitus in India
Year: 2025
Type: article
Abstract: in the initiation and management of pharmacotherapy for T2DM, with a particular focus on the role of vildagliptin and its fixed-dose combination (FDC) with metformin.
Author: S Manjula
Institution: Micro Labs (India)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4411733819
